Medicon Hellas S.A. Stock

Equities

MEDIC

GRS424003002

Advanced Medical Equipment & Technology

Market Closed - Athens S.E. 10:10:10 2024-06-21 EDT 5-day change 1st Jan Change
2.84 EUR +1.43% Intraday chart for Medicon Hellas S.A. +3.27% -14.71%

Financials

Sales 2022 20.77M 22.21M 30.41M Sales 2023 18.72M 20.01M 27.4M Capitalization 14.72M 15.73M 21.55M
Net income 2022 2M 2.14M 2.93M Net income 2023 1M 1.07M 1.46M EV / Sales 2022 0.83 x
Net Debt 2022 816K 872K 1.19M Net Debt 2023 2.19M 2.34M 3.2M EV / Sales 2023 0.9 x
P/E ratio 2022
6.46 x
P/E ratio 2023
11.1 x
Employees 174
Yield 2022
4.14%
Yield 2023
-
Free-Float 55.26%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.43%
1 week+3.27%
Current month-3.07%
1 month-1.73%
3 months-8.68%
6 months-12.62%
Current year-14.71%
More quotes
1 week
2.80
Extreme 2.8
2.87
1 month
2.67
Extreme 2.67
3.02
Current year
2.67
Extreme 2.67
3.49
1 year
2.67
Extreme 2.67
4.40
3 years
2.21
Extreme 2.21
5.40
5 years
1.50
Extreme 1.5
5.40
10 years
0.23
Extreme 0.233
5.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 70 17-06-29
Director of Finance/CFO - -
Investor Relations Contact 70 -
Members of the board TitleAgeSince
Director/Board Member 41 17-06-29
Director/Board Member 74 17-06-29
Director/Board Member 45 17-06-29
More insiders
Date Price Change Volume
24-06-21 2.84 +1.43% 4
24-06-20 2.8 -2.44% 116
24-06-19 2.87 +2.50% 4
24-06-18 2.8 -1.06% 31
24-06-17 2.83 +2.91% 6

Delayed Quote Athens S.E., June 21, 2024 at 10:10 am

More quotes
Medicon Hellas SA is a Greece-based company active in the health equipment sector. Its activities include research and development, production, and import and export of diagnostic products; the development of laboratory information systems; the import and distribution of in vitro diagnostics and automated analytical systems, such as Olympus for clinical chemistry, immunochemistry and lab automation, and Nihon Kohden for hematology, and the provision of cosmetic and body care products, such as make-up, anti-ageing and skin care products under the brand name Miss Beaute. Its laboratory information systems products include: Gi-Lab, which is a management system for medical laboratories; Gi-Maxima, a management program for medical centers, and Gi-Blood, which is an application that helps to connect various blood donation networks. On December 6, 2013, it merged by absorption of its subsidiary, Medicon Ltd.
More about the company